nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP4A11—Tretinoin—peripheral nervous system neoplasm	0.307	0.405	CbGbCtD
Pentamidine—CYP4A11—Cisplatin—peripheral nervous system neoplasm	0.131	0.173	CbGbCtD
Pentamidine—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0559	0.0737	CbGbCtD
Pentamidine—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0481	0.0634	CbGbCtD
Pentamidine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0336	0.0443	CbGbCtD
Pentamidine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0323	0.0426	CbGbCtD
Pentamidine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0269	0.0354	CbGbCtD
Pentamidine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0215	0.0283	CbGbCtD
Pentamidine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0154	0.0203	CbGbCtD
Pentamidine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0141	0.0186	CbGbCtD
Pentamidine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0141	0.0186	CbGbCtD
Pentamidine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0136	0.0179	CbGbCtD
Pentamidine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0131	0.0173	CbGbCtD
Pentamidine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0105	0.0139	CbGbCtD
Pentamidine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00601	0.00792	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0059	0.00779	CbGbCtD
Pentamidine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00551	0.00726	CbGbCtD
Pentamidine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00375	0.00495	CbGbCtD
Pentamidine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.000534	CcSEcCtD
Pentamidine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000533	CcSEcCtD
Pentamidine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000129	0.000532	CcSEcCtD
Pentamidine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000531	CcSEcCtD
Pentamidine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00053	CcSEcCtD
Pentamidine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000127	0.000526	CcSEcCtD
Pentamidine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000126	0.00052	CcSEcCtD
Pentamidine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00052	CcSEcCtD
Pentamidine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000126	0.000519	CcSEcCtD
Pentamidine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.000519	CcSEcCtD
Pentamidine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.000517	CcSEcCtD
Pentamidine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.000517	CcSEcCtD
Pentamidine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000125	0.000516	CcSEcCtD
Pentamidine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000125	0.000515	CcSEcCtD
Pentamidine—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000515	CcSEcCtD
Pentamidine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000124	0.000514	CcSEcCtD
Pentamidine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000124	0.000512	CcSEcCtD
Pentamidine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000124	0.000512	CcSEcCtD
Pentamidine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000123	0.00051	CcSEcCtD
Pentamidine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00051	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000507	CcSEcCtD
Pentamidine—Infection—Etoposide—peripheral nervous system neoplasm	0.000123	0.000507	CcSEcCtD
Pentamidine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000122	0.000506	CcSEcCtD
Pentamidine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000122	0.000506	CcSEcCtD
Pentamidine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000504	CcSEcCtD
Pentamidine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000503	CcSEcCtD
Pentamidine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000503	CcSEcCtD
Pentamidine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000121	0.0005	CcSEcCtD
Pentamidine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000121	0.000499	CcSEcCtD
Pentamidine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00012	0.000498	CcSEcCtD
Pentamidine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000498	CcSEcCtD
Pentamidine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00012	0.000498	CcSEcCtD
Pentamidine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00012	0.000498	CcSEcCtD
Pentamidine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000497	CcSEcCtD
Pentamidine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000496	CcSEcCtD
Pentamidine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000493	CcSEcCtD
Pentamidine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000493	CcSEcCtD
Pentamidine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000118	0.000486	CcSEcCtD
Pentamidine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000484	CcSEcCtD
Pentamidine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000484	CcSEcCtD
Pentamidine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000117	0.000482	CcSEcCtD
Pentamidine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000481	CcSEcCtD
Pentamidine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000478	CcSEcCtD
Pentamidine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000115	0.000477	CcSEcCtD
Pentamidine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000476	CcSEcCtD
Pentamidine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000476	CcSEcCtD
Pentamidine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00047	CcSEcCtD
Pentamidine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.000469	CcSEcCtD
Pentamidine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000465	CcSEcCtD
Pentamidine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000465	CcSEcCtD
Pentamidine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000112	0.000464	CcSEcCtD
Pentamidine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000112	0.000462	CcSEcCtD
Pentamidine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000461	CcSEcCtD
Pentamidine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000459	CcSEcCtD
Pentamidine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000111	0.000458	CcSEcCtD
Pentamidine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000456	CcSEcCtD
Pentamidine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00011	0.000455	CcSEcCtD
Pentamidine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000454	CcSEcCtD
Pentamidine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00011	0.000453	CcSEcCtD
Pentamidine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000109	0.000452	CcSEcCtD
Pentamidine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000448	CcSEcCtD
Pentamidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000108	0.000448	CcSEcCtD
Pentamidine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000447	CcSEcCtD
Pentamidine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000447	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000444	CcSEcCtD
Pentamidine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.000444	CcSEcCtD
Pentamidine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000107	0.000443	CcSEcCtD
Pentamidine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000442	CcSEcCtD
Pentamidine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000441	CcSEcCtD
Pentamidine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000106	0.00044	CcSEcCtD
Pentamidine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000106	0.00044	CcSEcCtD
Pentamidine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000439	CcSEcCtD
Pentamidine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000437	CcSEcCtD
Pentamidine—Pain—Etoposide—peripheral nervous system neoplasm	0.000106	0.000436	CcSEcCtD
Pentamidine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000106	0.000436	CcSEcCtD
Pentamidine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000436	CcSEcCtD
Pentamidine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000435	CcSEcCtD
Pentamidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000105	0.000432	CcSEcCtD
Pentamidine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000104	0.000431	CcSEcCtD
Pentamidine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000427	CcSEcCtD
Pentamidine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000421	CcSEcCtD
Pentamidine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000102	0.00042	CcSEcCtD
Pentamidine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.00042	CcSEcCtD
Pentamidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000101	0.000419	CcSEcCtD
Pentamidine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000101	0.000417	CcSEcCtD
Pentamidine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000101	0.000416	CcSEcCtD
Pentamidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000416	CcSEcCtD
Pentamidine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000415	CcSEcCtD
Pentamidine—Rash—Alitretinoin—peripheral nervous system neoplasm	9.97e-05	0.000412	CcSEcCtD
Pentamidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.96e-05	0.000412	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000411	CcSEcCtD
Pentamidine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.92e-05	0.00041	CcSEcCtD
Pentamidine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.00041	CcSEcCtD
Pentamidine—Headache—Alitretinoin—peripheral nervous system neoplasm	9.9e-05	0.000409	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	9.86e-05	0.000408	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000407	CcSEcCtD
Pentamidine—Urticaria—Etoposide—peripheral nervous system neoplasm	9.8e-05	0.000405	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000404	CcSEcCtD
Pentamidine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000403	CcSEcCtD
Pentamidine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.75e-05	0.000403	CcSEcCtD
Pentamidine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.75e-05	0.000403	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.000403	CcSEcCtD
Pentamidine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	9.73e-05	0.000402	CcSEcCtD
Pentamidine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.0004	CcSEcCtD
Pentamidine—Vomiting—Vincristine—peripheral nervous system neoplasm	9.68e-05	0.0004	CcSEcCtD
Pentamidine—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.66e-05	0.000399	CcSEcCtD
Pentamidine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000399	CcSEcCtD
Pentamidine—Rash—Vincristine—peripheral nervous system neoplasm	9.6e-05	0.000397	CcSEcCtD
Pentamidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.59e-05	0.000397	CcSEcCtD
Pentamidine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000396	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000396	CcSEcCtD
Pentamidine—Headache—Vincristine—peripheral nervous system neoplasm	9.54e-05	0.000394	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	9.41e-05	0.000389	CcSEcCtD
Pentamidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.39e-05	0.000388	CcSEcCtD
Pentamidine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.21e-05	0.000381	CcSEcCtD
Pentamidine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.000381	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000379	CcSEcCtD
Pentamidine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	9.09e-05	0.000376	CcSEcCtD
Pentamidine—Nausea—Vincristine—peripheral nervous system neoplasm	9.05e-05	0.000374	CcSEcCtD
Pentamidine—Flushing—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000374	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000373	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000372	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000371	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.00037	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000367	CcSEcCtD
Pentamidine—Asthenia—Etoposide—peripheral nervous system neoplasm	8.85e-05	0.000366	CcSEcCtD
Pentamidine—Chills—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000361	CcSEcCtD
Pentamidine—Pruritus—Etoposide—peripheral nervous system neoplasm	8.73e-05	0.000361	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.00036	CcSEcCtD
Pentamidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.56e-05	0.000354	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000352	CcSEcCtD
Pentamidine—Rash—Cisplatin—peripheral nervous system neoplasm	8.49e-05	0.000351	CcSEcCtD
Pentamidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.48e-05	0.000351	CcSEcCtD
Pentamidine—Erythema—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.00035	CcSEcCtD
Pentamidine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.44e-05	0.000349	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000346	CcSEcCtD
Pentamidine—Tension—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000344	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000343	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—peripheral nervous system neoplasm	8.23e-05	0.00034	CcSEcCtD
Pentamidine—Dizziness—Etoposide—peripheral nervous system neoplasm	8.16e-05	0.000337	CcSEcCtD
Pentamidine—Chills—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000334	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000333	CcSEcCtD
Pentamidine—Nausea—Cisplatin—peripheral nervous system neoplasm	8e-05	0.000331	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.00033	CcSEcCtD
Pentamidine—Vomiting—Etoposide—peripheral nervous system neoplasm	7.84e-05	0.000324	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000324	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.83e-05	0.000324	CcSEcCtD
Pentamidine—Rash—Etoposide—peripheral nervous system neoplasm	7.78e-05	0.000322	CcSEcCtD
Pentamidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.77e-05	0.000321	CcSEcCtD
Pentamidine—Headache—Etoposide—peripheral nervous system neoplasm	7.73e-05	0.00032	CcSEcCtD
Pentamidine—Tension—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000318	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000317	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000315	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000315	CcSEcCtD
Pentamidine—Syncope—Epirubicin—peripheral nervous system neoplasm	7.6e-05	0.000314	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000314	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.00031	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000308	CcSEcCtD
Pentamidine—Cough—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000306	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000306	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000304	CcSEcCtD
Pentamidine—Nausea—Etoposide—peripheral nervous system neoplasm	7.33e-05	0.000303	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—peripheral nervous system neoplasm	7.32e-05	0.000302	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.0003	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000298	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000298	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000298	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.19e-05	0.000297	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.000295	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000292	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000291	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—peripheral nervous system neoplasm	7.03e-05	0.000291	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.00029	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000288	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000286	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000286	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000285	CcSEcCtD
Pentamidine—Infection—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000284	CcSEcCtD
Pentamidine—Cough—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000283	CcSEcCtD
Pentamidine—Shock—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000281	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000281	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.77e-05	0.00028	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.00028	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000279	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000276	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000276	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000276	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.65e-05	0.000275	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000273	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000273	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.00027	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000267	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000267	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000265	CcSEcCtD
Pentamidine—Infection—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000263	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.000261	CcSEcCtD
Pentamidine—Shock—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.00026	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000259	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000259	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000258	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.000257	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000255	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000254	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000252	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000252	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000249	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000247	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000247	CcSEcCtD
Pentamidine—Constipation—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000245	CcSEcCtD
Pentamidine—Pain—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000245	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000241	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000239	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000238	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.000236	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000236	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000235	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000234	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000233	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.00023	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000228	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.000227	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000226	CcSEcCtD
Pentamidine—Pain—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000226	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000226	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000226	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.000218	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.000216	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000211	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.00021	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000209	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000209	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000205	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000202	CcSEcCtD
Pentamidine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000196	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000195	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.00019	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.57e-05	0.000189	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000187	CcSEcCtD
Pentamidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000182	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000181	CcSEcCtD
Pentamidine—Rash—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.00018	CcSEcCtD
Pentamidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.00018	CcSEcCtD
Pentamidine—Headache—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000179	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000175	CcSEcCtD
Pentamidine—Nausea—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.00017	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000168	CcSEcCtD
Pentamidine—Rash—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000167	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000167	CcSEcCtD
Pentamidine—Headache—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000166	CcSEcCtD
Pentamidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000157	CcSEcCtD
